Clinical Trial Update: Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 study of short-term combination therapy with escitalopram and gaboxadol for major depressive disorder completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Gaboxadol (gaboxadol)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2011-08-11